Back to Results
First PageMeta Content
Abortifacients / Fertility / Gynaecology / Antiandrogens / Mifepristone / Medical abortion / Misoprostol / Abortion / Clostridium sordellii / Medicine / Human reproduction / Reproduction


FAQs on Sepsis and Mifepristone Medical Abortion
Add to Reading List

Document Date: 2006-06-28 11:59:45


Open Document

File Size: 97,92 KB

Share Result on Facebook

Company

Danco Laboratories / New England Journal / New York Times / Brothers LP / /

Continent

Europe / /

Country

United States / /

Event

FDA Phase / /

MedicalCondition

Fatal infections / fatal penicillin-induced anaphylaxis / additional fatal infections / fatal allergic reactions / umbilical infection / Fatal Infection / C. sordellii infections / Anaphylaxis / reported infection / fever / Winikoff B. Infection / severe infection / C. sordellii infection / natural miscarriage / infection / similar infections / infections / deep skin infection / /

MedicalTreatment

Contraception / transplant surgery / orthopedic surgery / antibiotics / abdominal surgery / /

Organization

National Abortion Federation / FDA / FDA’s Center for Drug Evaluation and Research / /

Person

Arch Intern / Richard Hausknecht / /

Position

director / /

Product

After Abortion Pill / penicillin / misoprostol / Mifeprex / Although oral / abortion / /

ProvinceOrState

California / Washington / /

PublishedMedium

the New England Journal of Medicine / New York Times / /

URL

www.fda.gov/cder/drug/infopage/mifepristone/mifepristone-qa20050719.htm / http /

SocialTag